| Literature DB >> 28620797 |
Masao Omata1,2, Ann-Lii Cheng3, Norihiro Kokudo4, Masatoshi Kudo5, Jeong Min Lee6, Jidong Jia7, Ryosuke Tateishi8, Kwang-Hyub Han9, Yoghesh K Chawla10, Shuichiro Shiina11, Wasim Jafri12, Diana Alcantara Payawal13, Takamasa Ohki14, Sadahisa Ogasawara15, Pei-Jer Chen16, Cosmas Rinaldi A Lesmana17,18, Laurentius A Lesmana17, Rino A Gani18, Shuntaro Obi19, A Kadir Dokmeci20, Shiv Kumar Sarin21.
Abstract
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia-Pacific region, where HCC is one of the leading public health problems. Since the "Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines" meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia-Pacific region, which has a diversity of medical environments.Entities:
Keywords: APASL; Asia–Pacific; Hepatocellular carcinoma; Treatment algorithm
Mesh：
Year: 2017 PMID： 28620797 PMCID： PMC5491694 DOI： 10.1007/s12072-017-9799-9
Source DB: PubMed Journal: Hepatol Int ISSN： 1936-0533 Impact factor: 6.047